The exact science of stroke thrombolysis and the quiet art of patient selection

Brain

Volumn 136, Issue 12, 2013, Pages 3528-3553

  Balami, Joyce S ^a   Hadley, Gina ^b   Sutherland, Brad A ^b   Karbalai, Hasneen ^c   Buchan, Alastair M ^b,c  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Acute stroke; Interventional therapy; Multimodal imaging; Multimodal therapy; Thrombolytic therapy

Indexed keywords

ABCIXIMAB; ALTEPLASE; DABIGATRAN; DESMOTEPLASE; GLUCOSE; GLYCERYL TRINITRATE; HEPARIN; LABETALOL; NASARUPLASE BETA; NICARDIPINE; PLACEBO; TENECTEPLASE; UROKINASE; WARFARIN;

ANTICOAGULATION; ARTICLE; BASILAR ARTERY OBSTRUCTION; BLOOD CLOT LYSIS; BLOOD PRESSURE REGULATION; BRAIN ANGIOGRAPHY; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CHILDHOOD DISEASE; CLINICAL PROTOCOL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIASTOLIC BLOOD PRESSURE; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; DRUG DOSE ESCALATION; DRUG HALF LIFE; EVIDENCE BASED MEDICINE; FIBRINOLYTIC THERAPY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INTERNAL CAROTID ARTERY OCCLUSION; INTERNATIONAL NORMALIZED RATIO; LOW DRUG DOSE; MAGNETIC RESONANCE ANGIOGRAPHY; MATERNAL MORTALITY; MECHANICAL THROMBECTOMY; META ANALYSIS (TOPIC); MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; MULTICENTER STUDY (TOPIC); NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; ONSET AGE; OUTCOME ASSESSMENT; PATIENT SELECTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERFUSION WEIGHTED IMAGING; PHASE 3 CLINICAL TRIAL (TOPIC); PRACTICE GUIDELINE; PREGNANCY DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECANALIZATION; SEIZURE; STROKE PATIENT; SUSCEPTIBILITY WEIGHTED IMAGING; SYSTEMATIC REVIEW (TOPIC); SYSTOLIC BLOOD PRESSURE; TIME TO TREATMENT; TRANSCRANIAL DOPPLER;

EID: 84890726618     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awt201     Document Type: Article

References (274)

1. Abou-Chebl A, Bajzer CT, Krieger DW, Furlan AJ, Yadav JS. Multimodal therapy for the treatment of severe ischemic stroke combining GPIIb/IIIa antagonists and angioplasty after failure of thrombolysis. Stroke 2005; 36: 2286-8.
2. Adams HP Jr. Extending the time frame for emergency intravenous thrombolytic therapy for treatment of acute ischemic stroke. Curr Neurol Neurosci Rep 2009; 9: 3-5.
3. Adams HP Jr, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 1996a; 94: 1167-74.
4. Adams HP Jr, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, et al. Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association Stroke 1996b; 27: 1711-8.
5. Adams HP Jr, Davis PH, Leira EC, Chang KC, Bendixen BH, Clarke WR, et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999; 53: 126-31.
6. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 2007; 115: e478-534.
7. Adams HP Jr, Effron MB, Torner J, Davalos A, Frayne J, Teal P, et al. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke 2008; 39: 87-99.
8. Ahmed N, Davalos A, Eriksson N, Ford GA, Glahn J, Hennerici M, et al. Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: results from the Safe Implementation of Treatments in Stroke International Stroke Thrombolysis Register (SITS-ISTR). Arch Neurol 2010; 67: 1123-30.
9. Ahmed N, Wahlgren N, Brainin M, Castillo J, Ford GA, Kaste M, et al. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR). Stroke 2009; 40: 2442-9.
10. Ahn JY, Han IB, Chung SS, Chung YS, Kim SH, Yoon PH. Endovascular thrombolysis and stenting of a middle cerebral artery occlusion beyond 6 hours post-attack: special reference to the usefulness of diffusionperfusion MRI. Neurol Res 2006; 28: 881-5.
11. Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 2000; 283: 1145-50.
12. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006; 60: 508-17.
13. Alberts MJ, Felberg RA, Guterman LR, Levine SR. Atherosclerotic Peripheral Vascular Disease Symposium II: stroke intervention: state of the art. Circulation 2008; 118: 2845-51.
14. Alexandrov AV, Demchuk AM, Felberg RA, Christou I, Barber PA, Burgin WS, et al. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial doppler monitoring. Stroke 2000; 31: 610-4.
15. Alexandrov AV, Grotta JC. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 2002; 59: 862-7.
16. Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004; 351: 2170-8.
17. Alshekhlee A, Li CC, Chuang SY, Vora N, Edgell RC, Kitchener JM, et al. Does dementia increase risk of thrombolysis?: a case-control study. Neurology 2011; 76: 1575-80.
18. Alshekhlee A, Mohammadi A, Mehta S, Edgell RC, Vora N, Feen E, et al. Is thrombolysis safe in the elderly?: analysis of a national database. Stroke 2010; 41: 2259-64.
19. Alvarez-Sabin J, Molina CA, Montaner J, Arenillas JF, Huertas R, Ribo M, et al. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients. Stroke 2003; 34: 1235-41.
20. Amlie-Lefond C, de Veber G, Chan AK, Benedict S, Bernard T, Carpenter J, et al. Use of alteplase in childhood arterial ischaemic stroke: a multicentre, observational, cohort study. Lancet Neurol 2009; 8: 530-6.
21. Aviv RI, Mandelcorn J, Chakraborty S, Gladstone D, Malham S, Tomlinson G, et al. Alberta Stroke Program Early CT Scoring of CT perfusion in early stroke visualization and assessment. AJNR Am J Neuroradiol 2007; 28: 1975-80.
22. Awada A, Omojola MF, Obeid T. Late epileptic seizures after cerebral infarction. Acta Neurol Scand 1999; 99: 265-8.
23. Awadh M, MacDougall N, Santosh C, Teasdale E, Baird T, Muir KW. Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation. Stroke 2010; 41: 1990-5.
24. Balami JS, Chen RL, Sutherland BA, Buchan AM. Thrombolytic agents for acute ischaemic stroke treatment: the past, present and future. CNS Neurol Disord Drug Targets 2013a; 12: 145-54.
25. Balami JS, Sutherland BA, Buchan AM. Complications associated with recombinant tissue plasminogen activator therapy for acute ischaemic stroke. CNS Neurol Disord Drug Targets 2013b; 12: 155-69.
26. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 2000; 355: 1670-4.
27. Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 2001; 56: 1015-20.
28. Barreto AD, Martin-Schild S, Hallevi H, Morales MM, Abraham AT, Gonzales NR, et al. Thrombolytic therapy for patients who wake-up with stroke. Stroke 2009; 40: 827-32.
29. Bateman BT, Schumacher HC, Boden-Albala B, Berman MF, Mohr JP, Sacco RL, et al. Factors associated with in-hospital mortality after administration of thrombolysis in acute ischemic stroke patients: an analysis of the nationwide inpatient sample 1999 to 2002. Stroke 2006; 37: 440-6.
30. Baumann CR, Baumgartner RW, Gandjour J, von Budingen HC, Siegel AM, Georgiadis D. Good outcomes in ischemic stroke patients treated with intravenous thrombolysis despite regressing neurological symptoms. Stroke 2006; 37: 1332-3.
31. Berger C, Fiorelli M, Steiner T, Schabitz WR, Bozzao L, Bluhmki E, et al. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke 2001; 32: 1330-5.
32. Bladin CF, Alexandrov AV, Bellavance A, Bornstein N, Chambers B, Cote R, et al. Seizures after stroke: a prospective multicenter study. Arch Neurol 2000; 57: 1617-22.
33. Bonita R, Anderson CS, Broad JB, Jamrozik KD, Stewart-Wynne EG, Anderson NE. Stroke incidence and case fatality in Australasia. A comparison of the Auckland and Perth population-based stroke registers. Stroke 1994; 25: 552-7.
34. Bose A, Henkes H, Alfke K, Reith W, Mayer TE, Berlis A, et al. The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 2008; 29: 1409-13.
35. Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013; 368: 893-903.
36. Bunc M, Kocijancic IJ, Pregelj R, Dolenc VV. Multimodal therapy for the treatment of severe ischemic stroke combining endovascular embolectomy and stenting of long intracranial artery occlusion. Case Report Med 2010; 2010: 138023.
37. Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C. Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project. BMJ 1997; 315: 1582-7.
38. Busl KM, Nogueira RG, Yoo AJ, Hirsch JA, Schwamm LH, Rost NS. Prestroke dementia is associated with poor outcomes after reperfusion therapy among elderly stroke patients. J Stroke Cerebrovasc Dis 2011. [epub ahead of print].
39. Butcher K, Christensen S, Parsons M, De Silva DA, Ebinger M, Levi C, et al. Postthrombolysis blood pressure elevation is associated with hemorrhagic transformation. Stroke 2010; 41: 72-7.
40. Camilo O, Goldstein LB. Seizures and epilepsy after ischemic stroke. Stroke 2004; 35: 1769-75.
41. Casado-Naranjo I, Calle ML, Falcon A, Serrano A, Portilla JC, Ramirez-Moreno JM. Intravenous thrombolysis for acute stroke in patients with cancer. J Neurol Neurosurg Psychiatry 2011; 82: 1404-5.
42. Caso V, Paciaroni M, Agnelli G. Thrombolysis therapy in octogenarians. J Neurol Neurosurg Psychiatry 2007; 78: 662.
43. Cho AH, Sohn SI, Han MK, Lee DH, Kim JS, Choi CG, et al. Safety and efficacy of MRI-based thrombolysis in unclear-onset stroke. A preliminary report. Cerebrovasc Dis 2008; 25: 572-9.
44. Christou I, Alexandrov AV, Burgin WS, Wojner AW, Felberg RA, Malkoff M, et al. Timing of recanalization after tissue plasminogen activator therapy determined by transcranial doppler correlates with clinical recovery from ischemic stroke. Stroke 2000; 31: 1812-6.
45. Ciccone A, Valvassori L, Nichelatti M, Sgoifo A, Ponzio M, Sterzi R, et al. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013; 368: 904-13.
46. ClinicalTrials.gov. http://clinicaltrials.gov/ct2/home (2. May 2013 date last accessed).
47. Cocho D, Belvis R, Marti-Fabregas J, Molina-Porcel L, Diaz-Manera J, Aleu A, et al. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke. Neurology 2005; 64: 719-20.
48. Cohen JE, Gomori JM, Leker RR, Eichel R, Arkadir D, Itshayek E. Preliminary experience with the use of self-expanding stent as a thrombectomy device in ischemic stroke. Neurol Res 2011; 33: 214-9.
49. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-51.
50. Cordonnier C, van der Flier WM, Sluimer JD, Leys D, Barkhof F, Scheltens P. Prevalence and severity of microbleeds in a memory clinic setting. Neurology 2006; 66: 1356-60.
51. Costello CA, Campbell BC, Perez de la Ossa N, Zheng TH, Sherwin JC, Weir L, et al. Age over 80 years is not associated with increased hemorrhagic transformation after stroke thrombolysis. J Clin Neurosci 2012; 19: 360-3.
52. Cote R, Hachinski VC, Shurvell BL, Norris JW, Wolfson C. The Canadian Neurological Scale: a preliminary study in acute stroke. Stroke 1986; 17: 731-7.
53. Coutts SB, Demchuk AM, Barber PA, Hu WY, Simon JE, Buchan AM, et al. Interobserver variation of ASPECTS in real time. Stroke 2004a; 35: e103-5.
54. Coutts SB, Hill MD, Demchuk AM, Barber PA, Pexman JH, Buchan AM. ASPECTS reading requires training and experience. Stroke 2003; 34: e179.
55. Coutts SB, Lev MH, Eliasziw M, Roccatagliata L, Hill MD, Schwamm LH, et al. ASPECTS on CTA source images versus unenhanced CT: added value in predicting final infarct extent and clinical outcome. Stroke 2004b; 35: 2472-6.
56. Coutts SB, O'Reilly C, Hill MD, Steffenhagen N, Poppe AY, Boyko MJ, et al. Computed tomography and computed tomography angiography findings predict functional impairment in patients with minor stroke and transient ischaemic attack. Int J Stroke 2009; 4: 448-53.
57. Dapprich M, Boessenecker W. Fibrinolysis with alteplase in a pregnant woman with stroke. Cerebrovasc Dis 2002; 13: 290.
58. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009; 40: 2945-8.
59. Del Zotto E, Giossi A, Volonghi I, Costa P, Padovani A, Pezzini A. Stroke Res Treat 2011; 2011: 606780.
60. Delgado-Mederos R, Ribo M, Rovira A, Rubiera M, Munuera J, Santamarina E, et al. Prognostic significance of blood pressure variability after thrombolysis in acute stroke. Neurology 2008; 71: 552-8.
61. Delgado MG, Michel P, Naves M, Maeder P, Reichhart M, Wintermark M, et al. Early profiles of clinical evolution after intravenous thrombolysis in an unselected stroke population. J Neurol Neurosurg Psychiatry 2010; 81: 282-5.
62. Derex L, Hermier M, Adeleine P, Pialat JB, Wiart M, Berthezene Y, et al. Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator. J Neurol Neurosurg Psychiatry 2005; 76: 70-5.
63. Derex L, Nighoghossian N. Thrombolysis, stroke-unit admission and early rehabilitation in elderly patients. Nat Rev Neurol 2009; 5: 506-11.
64. Di Carlo A, Baldereschi M, Gandolfo C, Candelise L, Ghetti A, Maggi S, et al. Stroke in an elderly population: incidence and impact on survival and daily function. The Italian Longitudinal Study on Aging. Cerebrovasc Dis 2003; 16: 141-50.
65. Doerfler A, Forsting M, Reith W, Staff C, Heiland S, Schabitz WR, et al. Decompressive craniectomy in a rat model of "malignant" cerebral hemispheric stroke: experimental support for an aggressive therapeutic approach. J Neurosurg 1996; 85: 853-9.
66. Elford K, Leader A, Wee R, Stys PK. Stroke in ovarian hyperstimulation syndrome in early pregnancy treated with intra-arterial rt-PA. Neurology 2002; 59: 1270-2.
67. Engelter ST, Bonati LH, Lyrer PA. Intravenous thrombolysis in stroke patients of >4 or = 80 versus 5< 80 years of age-a systematic review across cohort studies. Age Ageing 2006; 35: 572-80.
68. ESO. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25: 457-507.
69. ESO. ESO Guidelines for Management of Ischaemic Stroke Update. 2009. http://www.eso-stroke.org/pdf/ESO-Guideline-Update-Jan- 2009.pdf (8 June 2012, date last accessed).
70. Fernandez-Cadenas I, Mendioroz M, Munuera J, Alvarez-Sabin J, Rovira A, Quiroga A, et al. Lower concentrations of thrombin-antithrombin complex (TAT) correlate to higher recanalisation rates among ischaemic stroke patients treated with t-PA. Thromb Haemost 2009; 102: 759-64.
71. Fields JD, Khatri P, Nesbit GM, Liu KC, Barnwell SL, Lutsep HL, et al. Meta-analysis of randomized intra-arterial thrombolytic trials for the treatment of acute stroke due to middle cerebral artery occlusion. J Neurointerv Surg 2011; 3: 151-5.
72. Fink JN, Kumar S, Horkan C, Linfante I, Selim MH, Caplan LR, et al. The stroke patient who woke up: clinical and radiological features, including diffusion and perfusion MRI. Stroke 2002; 33: 988-93.
73. Fischer U, Baumgartner A, Arnold M, Nedeltchev K, Gralla J, De Marchis GM, et al. What is a minor stroke? Stroke 2010; 41: 661-6.
74. Fonarow GC, Reeves MJ, Zhao X, Olson DM, Smith EE, Saver JL, et al. Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke. Circulation 2010; 121: 879-91.
75. Ford GA, Ahmed N, Azevedo E, Grond M, Larrue V, Lindsberg PJ, et al. Intravenous alteplase for stroke in those older than 80 years old. Stroke 2010; 41: 2568-74.
76. Fukuda I, Imazuru T, Osaka M, Watanabe K, Meguro K, Wada M. Thrombolytic therapy for delayed, in-hospital stroke after cardiac surgery. Ann Thorac Surg 2003; 76: 1293-5.
77. Fulgham JR, Ingall TJ, Stead LG, Cloft HJ, Wijdicks EF, Flemming KD. Management of acute ischemic stroke. Mayo Clin Proc 2004; 79: 1459-69.
78. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999; 282: 2003-11.
79. Furlan AJ, Eyding D, Albers GW, Al-Rawi Y, Lees KR, Rowley HA, et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006; 37: 1227-31.
80. Garcia AM, Egido JA, Garcia ME, Simal P. Thrombolysis for ischaemic stroke and glioblastoma multiforme: a case report. BMJ Case Rep 2009; 2009.
81. George MG, Tong X, McGruder H, Yoon P, Rosamond W, Winquist A, et al. Paul Coverdell National Acute Stroke Registry Surveillance-four states, 2005-2007. MMWR Surveill Summ 2009; 58: 1-23.
82. Georgiadis D, Engelter S, Tettenborn B, Hungerbuhler H, Luethy R, Muller F, et al. Early recurrent ischemic stroke in stroke patients undergoing intravenous thrombolysis. Circulation 2006; 114: 237-41.
83. Gladstone DJ, Black SE, Hakim AM. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 2002; 33: 2123-36.
84. Goldmakher GV, Camargo EC, Furie KL, Singhal AB, Roccatagliata L, Halpern EF, et al. Hyperdense basilar artery sign on unenhanced CT predicts thrombus and outcome in acute posterior circulation stroke. Stroke 2009; 40: 134-9.
85. Gonzales NR, Albright KC, Noser EA, Khaja AM, Shaltoni HM, Romman A, et al. "Mild Stroke" should not exclude patients from thrombolytic therapy. In: Abstracts From the International Stroke Conference; 2006, Kissimmee, Florida: Stroke (American Stroke Association). p. 621.
86. Graham GD. Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data. Stroke 2003; 34: 2847-50.
87. Grimm SA, DeAngelis LM. Intratumoral hemorrhage after thrombolysis in a patient with glioblastoma multiforme. Neurology 2007; 69: 936.
88. Grotta JC, Welch KM, Fagan SC, Lu M, Frankel MR, Brott T, et al. Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial. Stroke 2001; 32: 661-8.
89. Guerrero WR, Dababneh H, Eisenschenk S. The role of perfusion CT in identifying stroke mimics in the emergency room: a case of status epilepticus presenting with perfusion CT alterations. Int J Emerg Med 2012; 5: 4.
90. Gupta AC, Schaefer PW, Chaudhry ZA, Leslie-Mazwi TM, Chandra RV, Gonzalez RG, et al. Interobserver reliability of baseline noncontrast CT Alberta Stroke Program Early CT Score for intra-arterial stroke treatment selection. AJNR Am J Neuroradiol 2012; 33: 1046-9.
91. Gupta R, Al-Ali F, Thomas AJ, Horowitz MB, Barrow T, Vora NA, et al. Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke 2006a; 37: 2562-6.
92. Gupta R, Vora NA, Horowitz MB, Tayal AH, Hammer MD, Uchino K, et al. Multimodal reperfusion therapy for acute ischemic stroke: factors predicting vessel recanalization. Stroke 2006b; 37: 986-90.
93. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005; 36: 66-73.
94. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363: 768-74.
95. Hacke W, Furlan AJ, Al-Rawi Y, Davalos A, Fiebach JB, Gruber F, et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomized, double-blind, placebo-controlled study. Lancet Neurol 2009; 8: 141-50.
96. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317-29.
97. Halloran JI, Bekavac I. Unsuccessful tissue plasminogen activator treatment of acute stroke caused by a calcific embolus. J Neuroimaging 2004; 14: 385-7.
98. Hantson L, De Weerdt W, De Keyser J, Diener HC, Franke C, Palm R, et al. The European Stroke Scale. Stroke 1994; 25: 2215-9.
99. Harrer JU, Seet RC. Warfarin treatment and thrombolysis in acute stroke: are the procrastinators right? Neurology 2012; 79: 17-8.
100. Henkes H, Reinartz J, Lowens S, Miloslavski E, Roth C, Reith W, et al. A device for fast mechanical clot retrieval from intracranial arteries (Phenox clot retriever). Neurocrit Care 2006; 5: 134-40.
101. Henneman WJ, Sluimer JD, Cordonnier C, Baak MM, Scheltens P, Barkhof F, et al. MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population. Stroke 2009; 40: 492-8.
102. Heuschmann PU, Kolominsky-Rabas PL, Roether J, Misselwitz B, Lowitzsch K, Heidrich J, et al. Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy. JAMA 2004; 292: 1831-8.
103. Hill MD, Buchan AM. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ 2005; 172: 1307-12.
104. Hill MD, Kenney C, Dzialowski I, Boulanger JM, Demchuk AM, Barber PA, et al. Tissue window in Stroke Thrombolysis Study (TWIST): a safety study. Can J Neurol Sci 2013; 40: 17-20.
105. Hill MD, Lye T, Moss H, Barber PA, Demchuk AM, Newcommon NJ, et al. Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke. Neurology 2003a; 60: 1525-7.
106. Hill MD, Rowley HA, Adler F, Eliasziw M, Furlan A, Higashida RT, et al. Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke 2003b; 34: 1925-31.
107. Hopyan J, Ciarallo A, Dowlatshahi D, Howard P, John V, Yeung R, et al. Certainty of stroke diagnosis: incremental benefit with CT perfusion over noncontrast CT and CT angiography. Radiology 2010; 255: 142-53.
108. Hsieh HC, Chen CH. Tissue plasminogen activator use in a patient with acute ischemic stroke coexisting with meningioma. Clin Neurol Neurosurg 2009; 111: 562-3.
109. Huisa BN, Raman R, Ernstrom K, Tafreshi G, Stemer A, Meyer BC, et al. Alberta Stroke Program Early CT Score (ASPECTS) in patients with wake-up stroke. J Stroke Cerebrovasc Dis 2010; 19: 475-9.
110. IMS. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the interventional management of stroke study. Stroke 2004; 35: 904-11.
111. IMS. The Interventional Management of Stroke (IMS) II Study. Stroke 2007; 38: 2127-35.
112. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013; 44: 870-947.
113. Jimenez-Conde J, Ois A, Rodriguez-Campello A, Gomis M, Roquer J. Does sleep protect against ischemic stroke? Less frequent ischemic strokes but more severe ones. J Neurol 2007; 254: 782-8.
114. Johnson DM, Kramer DC, Cohen E, Rochon M, Rosner M, Weinberger J. Thrombolytic therapy for acute stroke in late pregnancy with intraarterial recombinant tissue plasminogen activator. Stroke 2005; 36: e53-5.
115. Johnston SC, Easton JD. Are patients with acutely recovered cerebral ischemia more unstable? Stroke 2003; 34: 2446-50.
116. Johnston SC, Leira EC, Hansen MD, Adams HP Jr. Early recovery after cerebral ischemia risk of subsequent neurological deterioration. Ann Neurol 2003; 54: 439-44.
117. Kakuda W, Lansberg MG, Thijs VN, Kemp SM, Bammer R, Wechsler LR, et al. Optimal definition for PWI/DWI mismatch in acute ischemic stroke patients. J Cereb Blood Flow Metab 2008; 28: 887-91.
118. Kasner SE. Clinical interpretation and use of stroke scales. Lancet Neurol 2006; 5 (7): 603-12.
119. Katzan IL, Hammer MD, Hixson ED, Furlan AJ, Abou-Chebl A, Nadzam DM. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol 2004; 61: 346-50.
120. Katzan IL, Masaryk TJ, Furlan AJ, Sila CA, Perl J 2nd, Andrefsky JC, et al. Intra-arterial thrombolysis for perioperative stroke after open heart surgery. Neurology 1999; 52: 1081-4.
121. Kerber CW, Wanke I, Bernard J Jr, Woo HH, Liu MW, Nelson PK. Rapid intracranial clot removal with a new device: the alligator retriever. AJNR Am J Neuroradiol 2007; 28: 860-3.
122. Kharitonova T, Ahmed N, Thoren M, Wardlaw JM, von Kummer R, Glahn J, et al. Hyperdense middle cerebral artery sign on admission CT scan-prognostic significance for ischaemic stroke patients treated with intravenous thrombolysis in the safe implementation of thrombolysis in Stroke International Stroke Thrombolysis Register. Cerebrovasc Dis 2009; 27: 51-9.
123. Khatri P, Conaway MR, Johnston KC. Ninety-day outcome rates of a prospective cohort of consecutive patients with mild ischemic stroke. Stroke 2012; 43: 560-2.
124. Khatri P, Khoury JC, Alwell K, Kleindorfer DO, Flaherty ML, Broderick JP, et al. "Mild" ischemic strokes have substantial rates of disability at 90 days. In: International Stroke Conference; 2008. New Orleans, Louisiana: Abstracts from International Stroke Conference, Stroke. p. 709.
125. Khatri P, Kleindorfer DO, Yeatts SD, Saver JL, Levine SR, Lyden PD, et al. Strokes with minor symptoms: an exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials. Stroke 2010; 41: 2581-6.
126. Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z, et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013; 368: 914-23.
127. Kim EY, Heo JH, Lee SK, Kim DJ, Suh SH, Kim J, et al. Prediction of thrombolytic efficacy in acute ischemic stroke using thin-section noncontrast CT. Neurology 2006; 67: 1846-8.
128. Kirchhof K, Sikinger M, Welzel T, Zoubaa S, Sartor K. [Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte-and fibrin-content of a thrombus?]. Rofo 2004; 176: 98-105.
129. Kleindorfer D, Kissela B, Schneider A, Woo D, Khoury J, Miller R, et al. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study. Stroke 2004; 35: e27-9.
130. Koennecke HC. Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications. Neurology 2006; 66: 165-71.
131. Koh JS, Lee SJ, Ryu CW, Kim HS. Safety and efficacy of mechanical thrombectomy with solitaire stent retrieval for acute ischemic stroke: a systematic review. Neurointervention 2012; 7: 1-9.
132. Kojima N, Naya M, Imoto H, Hara T, Deguchi T, Takahira H. Reproduction studies of GMK-527 (rt-PA). (III) Teratogenicity study in rabbits treated intravenously with GMK-527. Jap Pharmacol Ther 1988; 16: 107-23.
133. Kosior RK, Lauzon ML, Steffenhagen N, Kosior JC, Demchuk A, Frayne R. Atlas-based topographical scoring for magnetic resonance imaging of acute stroke. Stroke 2010; 41: 455-60.
134. Kothari R, Barsan W, Brott T, Broderick J, Ashbrock S. Frequency and accuracy of prehospital diagnosis of acute stroke. Stroke 1995a; 26: 937-41.
135. Kothari RU, Brott T, Broderick JP, Hamilton CA. Emergency physicians. Accuracy in the diagnosis of stroke. Stroke 1995b; 26: 2238-41.
136. Kwakkel G, Veerbeek JM, van Wegen EE, Nijland R, Harmeling-van der Wel BC, Dippel DW. Predictive value of the NIHSS for ADL outcome after ischemic hemispheric stroke: does timing of early assessment matter? J Neurol Sci 2010; 294: 57-61.
137. Kwiatkowski TG, Libman RB, Frankel M, Tilley BC, Morgenstern LB, Lu M, et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med 1999; 340: 1781-7.
138. Labiche LA, Malkoff M, Alexandrov AV. Residual flow signals predict complete recanalization in stroke patients treated with TPA. J Neuroimaging 2003; 13: 28-33.
139. Lamy C, Domigo V, Semah F, Arquizan C, Trystram D, Coste J, et al. Early and late seizures after cryptogenic ischemic stroke in young adults. Neurology 2003; 60: 400-4.
140. Lansberg MG, Thijs VN, Bammer R, Kemp S, Wijman CA, Marks MP, et al. Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Stroke 2007; 38: 2275-8.
141. Larrue V, von Kummer R, del Zoppo G, Bluhmki E. Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study. Stroke 1997; 28: 957-60.
142. Latchaw RE, Alberts MJ, Lev MH, Connors JJ, Harbaugh RE, Higashida RT, et al. Recommendations for imaging of acute ischemic stroke: a scientific statement from the American Heart Association. Stroke 2009; 40: 3646-78.
143. Lee SJ, Saver JL, Liebeskind DS, Ali L, Ovbiagele B, Kim D, et al. Safety of intravenous fibrinolysis in imaging-confirmed single penetrator artery infarcts. Stroke 2010; 41: 2587-91.
144. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 375: 1695-703.
145. Leiva-Salinas C, Wintermark M, Kidwell CS. Neuroimaging of cerebral ischemia and infarction. Neurotherapeutics 2011; 8: 19-27.
146. Leker RR, Eichel R, Arkadir D, Gomori JM, Raphaeli G, Ben-Hur T, et al. Multi-modal reperfusion therapy for patients with acute anterior circulation stroke in Israel. Stroke 2009; 40: 3627-30.
147. Leonhardt G, Gaul C, Nietsch HH, Buerke M, Schleussner E. Thrombolytic therapy in pregnancy. J Thromb Thrombolysis 2006; 21: 271-6.
148. Levy EI, Ecker RD, Horowitz MB, Gupta R, Hanel RA, Sauvageau E, et al. Stent-assisted intracranial recanalization for acute stroke: early results. Neurosurgery 2006; 58: 458-63.
149. Levy EI, Siddiqui AH, Crumlish A, Snyder KV, Hauck EF, Fiorella DJ, et al. First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke). Stroke 2009; 40: 3552-6.
150. Lewandowski CA, Frankel M, Tomsick TA, Broderick J, Frey J, Clark W, et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999; 30: 2598-605.
151. Liebig T, Reinartz J, Hannes R, Miloslavski E, Henkes H. Comparative in vitro study of five mechanical embolectomy systems: effectiveness of clot removal and risk of distal embolization. Neuroradiology 2008; 50: 43-52.
152. Lin DD, Gailloud P, Beauchamp NJ, Aldrich EM, Wityk RJ, Murphy KJ. Combined stent placement and thrombolysis in acute vertebrobasilar ischemic stroke. AJNR Am J Neuroradiol 2003; 24: 1827-33.
153. Lindsberg PJ, Mattle HP. Therapy of basilar artery occlusion: a systematic analysis comparing intra-arterial and intravenous thrombolysis. Stroke 2006; 37: 922-8.
154. Lou M, Safdar A, Mehdiratta M, Kumar S, Schlaug G, Caplan L, et al. The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis. Neurology 2008; 71: 1417-23.
155. Mackey J, Kleindorfer D, Sucharew H, Moomaw CJ, Kissela BM, Alwell K, et al. Population-based study of wake-up strokes. Neurology 2011; 76: 1662-7.
156. Macleod MR, Davis SM, Mitchell PJ, Gerraty RP, Fitt G, Hankey GJ, et al. Results of a multicentre, randomized controlled trial of intraarterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovasc Dis 2005; 20: 12-7.
157. Magid D, Naviaux N, Wears RL. Stroking the data: re-analysis of the NINDS trial. Ann Emerg Med 2005; 45: 385-7.
158. Majersik JJ, Smith MA, Zahuranec DB, Sanchez BN, Morgenstern LB. Population-based analysis of the impact of expanding the time window for acute stroke treatment. Stroke 2007; 38: 3213-7.
159. Manawadu D, Bodla S, Keep J, Jarosz J, Kalra L. An observational study of thrombolysis outcomes in wake-up ischemic stroke patients. Stroke 2013; 44: 427-31.
160. Manno EM, Nichols DA, Fulgham JR, Wijdicks EF. Computed tomographic determinants of neurologic deterioration in patients with large middle cerebral artery infarctions. Mayo Clin Proc 2003; 78: 156-60.
161. Marini C, Baldassarre M, Russo T, De Santis F, Sacco S, Ciancarelli I, et al. Burden of first-ever ischemic stroke in the oldest old: evidence from a population-based study. Neurology 2004; 62: 77-81.
162. Martin-Schild S, Hallevi H, Albright KC, Khaja AM, Barreto AD, Gonzales NR, et al. Aggressive blood pressure-lowering treatment before intravenous tissue plasminogen activator therapy in acute ischemic stroke. Arch Neurol 2008; 65: 1174-8.
163. Masrur S, Abdullah AR, Smith EE, Hidalgo R, El-Ghandour A, Rordorf G, et al. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy. J Stroke Cerebrovasc Dis 2011; 20: 124-30.
164. Mateen FJ, Buchan AM, Hill MD. Outcomes of thrombolysis for acute ischemic stroke in octogenarians versus nonagenarians. Stroke 2010; 41: 1833-5.
165. Mateen FJ, Nasser M, Spencer BR, Freeman WD, Shuaib A, Demaerschalk BM, et al. Outcomes of intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 90 years or older. Mayo Clin Proc 2009; 84: 334-8.
166. Mazighi M, Meseguer E, Labreuche J, Amarenco P. Bridging therapy in acute ischemic stroke: a systematic review and meta-analysis. Stroke 2012; 43: 1302-8.
167. Mazighi M, Serfaty JM, Labreuche J, Laissy JP, Meseguer E, Lavallee PC, et al. Comparison of intravenous alteplase with a combined intravenous- endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALIZE study): a prospective cohort study. Lancet Neurol 2009; 8: 802-9.
168. Mazya M, Egido JA, Ford GA, Lees KR, Mikulik R, Toni D, et al. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score. Stroke 2012; 43: 1524-31.
169. Mendez JC, Masjuan J, Garcia N, de Lecinana M. Successful intra-arterial thrombolysis for acute ischemic stroke in the immediate postpartum period: case report. Cardiovasc Intervent Radiol 2008; 31: 193-5.
170. Miedema I, Luijckx GJ, De Keyser J, Koch M, Uyttenboogaart M. Thrombolytic therapy for ischaemic stroke in patients using warfarin: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2012; 83: 537-40.
171. Mihout M, Cordonnier C, Girard-Buttaz I, Leys D. Thrombolysis for ischaemic stroke: impact of the extension of the time-window in daily practice. J Neurol Neurosurg Psychiatry 2012; 83: 227-8.
172. Mishra NK, Ahmed N, Andersen G, Egido JA, Lindsberg PJ, Ringleb PA, et al. Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive. BMJ 2010a; 341: c6046.
173. Mishra NK, Albers GW, Davis SM, Donnan GA, Furlan AJ, Hacke W, et al. Mismatch-based delayed thrombolysis: a meta-analysis. Stroke 2010b; 41: e25-33.
174. Molina CA, Ribo M, Rubiera M, Montaner J, Santamarina E, Delgado-Mederos R, et al. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke 2006; 37: 425-9.
175. Moradiya Y, Janjua N. Presentation and outcomes of "Wake-Up Strokes" in a large randomized stroke trial: analysis of data from the International Stroke Trial. J Stroke Cerebrovasc Dis 2012. [epub ahead of print].
176. Murugappan A, Coplin WM, Al-Sadat AN, McAllen KJ, Schwamm LH, Wechsler LR, et al. Thrombolytic therapy of acute ischemic stroke during pregnancy. Neurology 2006; 66: 768-70.
177. Nadeau JO, Fang J, Kapral MK, Silver FL, Hill MD. Outcome after stroke upon awakening. Can J Neurol Sci 2005; 32: 232-6.
178. Nagel S, Schellinger PD, Hartmann M, Juettler E, Huttner HB, Ringleb P, et al. Therapy of acute basilar artery occlusion: intraarterial thrombolysis alone vs bridging therapy. Stroke 2009; 40: 140-6.
179. Nakano S, Iseda T, Yoneyama T, Kawano H, Wakisaka S. Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion: an alternative option to intra-arterial thrombolysis. Stroke 2002; 33: 2872-6.
180. Nakano S, Wakisaka S, Yoneyama T, Kawano H. Reperfusion therapy for acute middle cerebral artery trunk occlusion. Direct percutaneous transluminal angioplasty versus intra-arterial thrombolysis. Interv Neuroradiol 2004; 10 (Suppl 1): 71-5.
181. Natarajan SK, Snyder KV, Siddiqui AH, Ionita CC, Hopkins LN, Levy EI. Safety and effectiveness of endovascular therapy after 8 hours of acute ischemic stroke onset and wake-up strokes. Stroke 2009; 40: 3269-74.
182. Nedeltchev K, Schwegler B, Haefeli T, Brekenfeld C, Gralla J, Fischer U, et al. Outcome of stroke with mild or rapidly improving symptoms. Stroke 2007; 38: 2531-5.
183. Neil W, Ovbiagele B. Intravenous thrombolysis in ischemic stroke patients with intracranial neoplasms: two cases and a literature review. Case Rep Med 2011; 2011: 503758.
184. Nguyen TN, Babikian VL, Romero R, Pikula A, Kase CS, Jovin TG, et al. Intra-arterial treatment methods in acute stroke therapy. Front Neurol 2011; 2: 9.
185. NINDS. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333: 1581-7.
186. NINDS. Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke 1997a; 28: 2119-25.
187. NINDS. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. Stroke 1997b; 28: 2109-18.
188. NINDS. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience. Ann Emerg Med 2005; 46: 243-52.
189. Nogueira RG, Schwamm LH, Buonanno FS, Koroshetz WJ, Yoo AJ, Rabinov JD, et al. Low-pressure balloon angioplasty with adjuvant pharmacological therapy in patients with acute ischemic stroke caused by intracranial arterial occlusions. Neuroradiology 2008; 50: 331-40.
190. Nogueira RG, Smith WS. Safety and efficacy of endovascular thrombectomy in patients with abnormal hemostasis: pooled analysis of the MERCI and multi MERCI trials. Stroke 2009; 40: 516-22.
191. Paliwal PR, Ahmad A, Shen L, Yeo LL, Loh PK, Ng KW, et al. Persistence of hyperdense middle cerebral artery sign on follow-up CT scan after intravenous thrombolysis is associated with poor outcome. Cerebrovasc Dis 2012; 33: 446-52.
192. Palumbo V, Boulanger JM, Hill MD, Inzitari D, Buchan AM, Investigators C. Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke. Neurology 2007; 68: 1020-4.
193. Park H, Hwang GJ, Jin SC, Bang JS, Oh CW, Kwon OK. Intra-arterial thrombolysis using double devices: mechanicomechanical or chemicomechanical techniques. J Korean Neurosurg Soc 2012; 51: 75-80.
194. Parsons M, Spratt N, Bivard A, Campbell B, Chung K, Miteff F, et al. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med 2012; 366: 1099-107.
195. Pohlmann-Eden B, Bruckmeir J. Predictors and dynamics of posttraumatic epilepsy. Acta Neurol Scand 1997; 95: 257-62.
196. Poppe AY, Majumdar SR, Jeerakathil T, Ghali W, Buchan AM, Hill MD. Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis. Diabetes Care 2009; 32: 617-22.
197. Puetz V, Dzialowski I, Hill MD, Subramaniam S, Sylaja PN, Krol A, et al. Intracranial thrombus extent predicts clinical outcome, final infarct size and hemorrhagic transformation in ischemic stroke: the clot burden score. Int J Stroke 2008a; 3: 230-6.
198. Puetz V, Sylaja PN, Coutts SB, Hill MD, Dzialowski I, Mueller P, et al. Extent of hypoattenuation on CT angiography source images predicts functional outcome in patients with basilar artery occlusion. Stroke 2008b; 39: 2485-90.
199. Pundik S, McWilliams-Dunnigan L, Blackham KL, Kirchner HL, Sundararajan S, Sunshine JL, et al. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke. J Stroke Cerebrovasc Dis 2008; 17: 266-72.
200. Putaala J, Sairanen T, Meretoja A, Lindsberg PJ, Tiainen M, Liebkind R, et al. Post-thrombolytic hyperglycemia and 3-month outcome in acute ischemic stroke. Cerebrovasc Dis 2011; 31: 83-92.
201. Rajajee V, Kidwell C, Starkman S, Ovbiagele B, Alger JR, Villablanca P, et al. Early MRI and outcomes of untreated patients with mild or improving ischemic stroke. Neurology 2006; 67: 980-4.
202. Raphaeli G, Eichel R, Ben-Hur T, Leker RR, Cohen JE. Multimodal reperfusion therapy in patients with acute basilar artery occlusion. Neurosurgery 2009; 65: 548-52.
203. Ravi A, Rao VR, Klein JP. Dystextia: acute stroke in the modern age. JAMA Neurol 2013; 70: 404-5.
204. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007; 38: 967-73.
205. Ribo M, Alvarez-Sabin J, Montaner J, Romero F, Delgado P, Rubiera M, et al. Temporal profile of recanalization after intravenous tissue plasminogen activator: selecting patients for rescue reperfusion techniques. Stroke 2006; 37: 1000-4.
206. Ribo M, Molina C, Montaner J, Rubiera M, Delgado-Mederos R, Arenillas JF, et al. Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients. Stroke 2005; 36: 1705-9.
207. Ringleb PA, Schwark C, Kohrmann M, Kulkens S, Juttler E, Hacke W, et al. Thrombolytic therapy for acute ischaemic stroke in octogenarians: selection by magnetic resonance imaging improves safety but does not improve outcome. J Neurol Neurosurg Psychiatry 2007; 78: 690-3.
208. Rizos T, Horstmann S, Jenetzky E, Spindler M, Gumbinger C, Mohlenbruch M, et al. Oral anticoagulants-a frequent challenge for the emergency management of acute ischemic stroke. Cerebrovasc Dis 2012; 34: 411-8.
209. Rohde S, Haehnel S, Herweh C, Pham M, Stampfl S, Ringleb PA, et al. Mechanical thrombectomy in acute embolic stroke: preliminary results with the revive device. Stroke 2011; 42: 2954-6.
210. Ronning OM, Dahl A, Bakke SJ, Hussain AI, Deilkas E. Stroke in the puerperium treated with intra-arterial rt-PA. J Neurol Neurosurg Psychiatry 2010; 81: 585-6.
211. Roth C, Papanagiotou P, Behnke S, Walter S, Haass A, Becker C, et al. Stent-assisted mechanical recanalization for treatment of acute intracerebral artery occlusions. Stroke 2010; 41: 2559-67.
212. Rubiera M, Alvarez-Sabin J, Ribo M, Montaner J, Santamarina E, Arenillas JF, et al. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke. Stroke 2005; 36: 1452-6.
213. Ryvlin P, Montavont A, Nighoghossian N. Optimizing therapy of seizures in stroke patients. Neurology 2006; 67 (12 Suppl 4): S3-9.
214. Sacco RL, Chong JY, Prabhakaran S, Elkind MS. Experimental treatments for acute ischaemic stroke. Lancet 2007; 369: 331-41.
215. Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomized controlled trial. Lancet 2012; 379: 2352-63.
216. Saposnik G, Fang J, Kapral MK, Tu JV, Mamdani M, Austin P, et al. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke. Stroke 2012a; 43: 1315-22.
217. Saposnik G, Hill MD, O'Donnell M, Fang J, Hachinski V, Kapral MK. Variables associated with 7-day, 30-day, and 1-year fatality after ischemic stroke. Stroke 2008; 39: 2318-24.
218. Saposnik G, Kapral MK, Cote R, Rochon PA, Wang J, Raptis S, et al. Is pre-existing dementia an independent predictor of outcome after stroke? A propensity score-matched analysis. J Neurol 2012b; 259: 2366-75.
219. Saposnik G, Kapral MK, Coutts SB, Fang J, Demchuk AM, Hill MD. Do all age groups benefit from organized inpatient stroke care? Stroke 2009; 40: 3321-7.
220. Saqqur M, Molina CA, Salam A, Siddiqui M, Ribo M, Uchino K, et al. Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler study. Stroke 2007a; 38: 69-74.
221. Saqqur M, Tsivgoulis G, Molina CA, Demchuk AM, Shuaib A, Alexandrov AV. Residual flow at the site of intracranial occlusion on transcranial Doppler predicts response to intravenous thrombolysis: a multi-center study. Cerebrovasc Dis 2009; 27: 5-12.
222. Saqqur M, Uchino K, Demchuk AM, Molina CA, Garami Z, Calleja S, et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007b; 38: 948-54.
223. Saver JL, Yafeh B. Confirmation of tPA treatment effect by baseline severity-adjusted end point reanalysis of the NINDS-tPA stroke trials. Stroke 2007; 38: 414-6.
224. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in ischemic stroke-background and study protocol. Scandinavian Stroke Study Group. Stroke 1985; 16: 885-90.
225. Schellinger PD, Fiebach JB, Hacke W. Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status. Stroke 2003; 34: 575-83.
226. Schellinger PD, Jansen O, Fiebach JB, Pohlers O, Ryssel H, Heiland S, et al. Feasibility and practicality of MR imaging of stroke in the management of hyperacute cerebral ischemia. AJNR Am J Neuroradiol 2000; 21: 1184-9.
227. Schumacher HC, Bateman BT, Boden-Albala B, Berman MF, Mohr JP, Sacco RL, et al. Use of thrombolysis in acute ischemic stroke: analysis of the Nationwide Inpatient Sample 1999 to 2004. Ann Emerg Med 2007; 50: 99-107.
228. Schwab S, Steiner T, Aschoff A, Schwarz S, Steiner HH, Jansen O, et al. Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke 1998; 29: 1888-93.
229. Schwamm LH, Pancioli A, Acker JE 3rd, Goldstein LB, Zorowitz RD, Shephard TJ, et al. Recommendations for the establishment of stroke systems of care: recommendations from the American stroke association's task force on the development of stroke systems. Circulation 2005; 111: 1078-91.
230. Seifert CL, Sprenger T, Mucke T, Foerschler A, Poppert H, Hemmer B, et al. Systemic thrombolysis in ischemic stroke after recent oral surgery and management of oral cavity bleeding. Ann Emerg Med 2011; 57: 517-9.
231. Selim M, Kumar S, Fink J, Schlaug G, Caplan LR, Linfante I. Seizure at stroke onset: should it be an absolute contraindication to thrombolysis? Cerebrovasc Dis 2002; 14: 54-7.
232. Serena J, Davalos A, Segura T, Mostacero E, Castillo J. Stroke on awakening: looking for a more rational management. Cerebrovasc Dis 2003; 16: 128-33.
233. Sharshar T, Lamy C, Mas JL. Incidence and causes of strokes associated with pregnancy and puerperium. A study in public hospitals of Ile de France. Stroke in Pregnancy Study Group. Stroke 1995; 26: 930-6.
234. Shinton RA, Gill JS, Melnick SC, Gupta AK, Beevers DG. The frequency, characteristics and prognosis of epileptic seizures at the onset of stroke. J Neurol Neurosurg Psychiatry 1988; 51: 273-6.
235. Silva GS, Lima FO, Camargo EC, Smith WS, Singhal AB, Greer DM, et al. Wake-up stroke: clinical and neuroimaging characteristics. Cerebrovasc Dis 2010; 29: 336-42.
236. Silver B, Demaerschalk B, Merino JG, Wong E, Tamayo A, Devasenapathy A, et al. Improved outcomes in stroke thrombolysis with pre-specified imaging criteria. Can J Neurol Sci 2001; 28: 113-9.
237. Simolke GA, Cox SM, Cunningham FG. Cerebrovascular accidents complicating pregnancy and the puerperium. Obstet Gynecol 1991; 78: 37-42.
238. Simon JE, Morgan SC, Pexman JH, Hill MD, Buchan AM. CT assessment of conjugate eye deviation in acute stroke. Neurology 2003; 60: 135-7.
239. Simon JE, Sandler DL, Pexman JH, Hill MD, Buchan AM. Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke?-The Calgary experience. Age Ageing 2004; 33: 143-9.
240. Singer OC, Kurre W, Humpich MC, Lorenz MW, Kastrup A, Liebeskind DS, et al. Risk assessment of symptomatic intracerebral hemorrhage after thrombolysis using DWI-ASPECTS. Stroke 2009; 40: 2743-8.
241. Smith EE, Abdullah AR, Petkovska I, Rosenthal E, Koroshetz WJ, Schwamm LH. Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke. Stroke 2005a; 36: 2497-9.
242. Smith EE, Fonarow GC, Reeves MJ, Cox M, Olson DM, Hernandez AF, et al. Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from Get With The Guidelines-Stroke. Stroke 2011; 42: 3110-5.
243. Smith WS. Intra-arterial thrombolytic therapy for acute basilar occlusion: pro. Stroke 2007; 38 (Suppl 2): 701-3.
244. Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008; 39: 1205-12.
245. Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005b; 36: 1432-8.
246. Steffenhagen N, Hill MD, Poppe AY, Buchan AM, Coutts SB. Should you thrombolyse all or any stroke patients with baseline National Institutes of Health stroke scale scores 5 < or = 5? Cerebrovasc Dis 2009; 28: 201-2.
247. Strbian D, Engelter S, Michel P, Meretoja A, Sekoranja L, Ahlhelm FJ, et al. Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score. Ann Neurol 2012; 71: 634-41.
248. Strbian D, Sairanen T, Rantanen K, Piironen K, Atula S, Tatlisumak T, et al. Characteristics and outcome of ischemic stroke patients who are free of symptoms at 24 hours following thrombolysis. Cerebrovasc Dis 2011; 31: 37-42.
249. Stroke Unit Trialists' Collaboration. Collaborative systematic review of the randomized trials of organized inpatient (stroke unit) care after stroke. Stroke Unit Trialists' Collaboration. BMJ 1997; 314: 1151-9.
250. Stroke Unit Trialists' Collaboration. Organized inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 2007; 4: CD000197.
251. Suchkova V, Siddiqi FN, Carstensen EL, Dalecki D, Child S, Francis CW. Enhancement of fibrinolysis with 40-kHz ultrasound. Circulation 1998; 98: 1030-5.
252. Sylaja PN, Cote R, Buchan AM, Hill MD. Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study. J Neurol Neurosurg Psychiatry 2006a; 77: 826-9.
253. Sylaja PN, Dzialowski I, Krol A, Roy J, Federico P, Demchuk AM. Role of CT angiography in thrombolysis decision-making for patients with presumed seizure at stroke onset. Stroke 2006b; 37: 915-7.
254. Tan IY, Demchuk AM, Hopyan J, Zhang L, Gladstone D, Wong K, et al. CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct. AJNR Am J Neuroradiol 2009; 30: 525-31.
255. Tan JC, Dillon WP, Liu S, Adler F, Smith WS, Wintermark M. Systematic comparison of perfusion-CT and CT-angiography in acute stroke patients. Ann Neurol 2007; 61: 533-43.
256. Tanaka E, Mizuno F, Ohtsuka T, Komatsu K, Umeshita C, Mizusawa R, et al. Reproduction studies of GMK-527 (rt-PA). (II) Teratogenicity study in rats treated intravenously with GMK-527. Jap Pharmacol Ther 1988; 16: 93-106.
257. The Helsinki Stroke Thrombolysis Registry Group. Cerebral edema in acute ischemic stroke patients treated with intravenous thrombolysis. Int J Stroke 2012. [epub ahead of print].
258. Todo K, Moriwaki H, Saito K, Tanaka M, Oe H, Naritomi H. Early CT findings in unknown-onset and wake-up strokes. Cerebrovasc Dis 2006; 21: 367-71.
259. Tomsick T, Brott T, Barsan W, Broderick J, Haley EC, Spilker J, et al. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. AJNR Am J Neuroradiol 1996; 17: 79-85.
260. Torres-Mozqueda F, He J, Yeh IB, Schwamm LH, Lev MH, Schaefer PW, et al. An acute ischemic stroke classification instrument that includes CT or MR angiography: the Boston Acute Stroke Imaging Scale. AJNR Am J Neuroradiol 2008; 29: 1111-7.
261. Tsivgoulis G, Eggers J, Ribo M, Perren F, Saqqur M, Rubiera M, et al. Safety and efficacy of ultrasound-enhanced thrombolysis: a comprehensive review and meta-analysis of randomized and nonrandomized studies. Stroke 2010; 41: 280-7.
262. Tsivgoulis G, Saqqur M, Sharma VK, Lao AY, Hill MD, Alexandrov AV. Association of pretreatment blood pressure with tissue plasminogen activator-induced arterial recanalization in acute ischemic stroke. Stroke 2007; 38: 961-6.
263. Ueda T, Sakaki S, Nochide I, Kumon Y, Kohno K, Ohta S. Angioplasty after intra-arterial thrombolysis for acute occlusion of intracranial arteries. Stroke 1998; 29: 2568-74.
264. Virgil. The Aeneid. Penguin Classics 19 BC Translated by W.F. Jackson Knight, 1956; 321.
265. von Kummer R. Treatment of acute stroke: a misconception. Neuroradiology 2010; 52: 337-9.
266. von Kummer R, Holle R, Gizyska U, Hofmann E, Jansen O, Petersen D, et al. Interobserver agreement in assessing early CT signs of middle cerebral artery infarction. AJNR Am J Neuroradiol 1996; 17: 1743-8.
267. Wahlgren N. Thrombectomy REvascularization of large Vessel Occlusions in acute ischemic stroke (TREVO). In: International Stroke Conference. New Orleans, 2012.
268. Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITSMOST): an observational study. Lancet 2007; 369: 275-82.
269. Wahlgren N, Ahmed N, Davalos A, Hacke W, Millan M, Muir K, et al. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITSISTR): an observational study. Lancet 2008; 372: 1303-9.
270. Warach S, Latour LL. Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke 2004; 35 (11 Suppl 1): 2659-61.
271. Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL, et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet 2012; 379: 2364-72.
272. Wiese KM, Talkad A, Mathews M, Wang D. Intravenous recombinant tissue plasminogen activator in a pregnant woman with cardioembolic stroke. Stroke 2006; 37: 2168-9.
273. Xian Y, Liang L, Smith EE, Schwamm LH, Reeves MJ, Olson DM, et al. Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. JAMA 2012; 307: 2600-8.
274. Zeevi N, Chhabra J, Silverman IE, Lee NS, McCullough LD. Acute stroke management in the elderly. Cerebrovasc Dis 2007; 23: 304-8.